Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3238822rdf:typepubmed:Citationlld:pubmed
pubmed-article:3238822lifeskim:mentionsumls-concept:C0007807lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0010294lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0020684lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0043314lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0935936lld:lifeskim
pubmed-article:3238822lifeskim:mentionsumls-concept:C0812409lld:lifeskim
pubmed-article:3238822pubmed:issue3lld:pubmed
pubmed-article:3238822pubmed:dateCreated1989-4-27lld:pubmed
pubmed-article:3238822pubmed:abstractTextThe purine metabolites hypoxanthine, xanthine and urate as well as creatinine were measured in cerebrospinal fluid (CSF) from two groups of patients and a reference sample group. In one of the patient groups lumbar CSF was collected in 2 ml portions until a total volume of 14 ml was withdrawn. Every second portion was analysed for its content of the metabolites in focus. In the other patient group both cisternal CSF and a fixed volume (20 ml) of lumbar CSF were obtained and analysed. An increase in concentration of hypoxanthine, xanthine and creatinine and a decrease in urate concentration was found in the successive CSF specimens. The mean individual increase in hypoxanthine concentration between the first and the last 2 ml portion was as high as 39.6%, while it was lower for xanthine, 21.5%, and creatinine, 6.7%. The decrease in urate concentration was 17.2%. The results from the other patient group were in good agreement with these findings. The concentrations in the cisternal CSF was 162% of that in lumbar CSF for hypoxanthine, 155% for xanthine, 123% for creatinine and 80% for urate. Mechanisms behind inter- and intraindividual differences in gradients are discussed.lld:pubmed
pubmed-article:3238822pubmed:languageenglld:pubmed
pubmed-article:3238822pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:citationSubsetIMlld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3238822pubmed:statusMEDLINElld:pubmed
pubmed-article:3238822pubmed:issn0300-9734lld:pubmed
pubmed-article:3238822pubmed:authorpubmed-author:DegrellIIlld:pubmed
pubmed-article:3238822pubmed:authorpubmed-author:HettaJJlld:pubmed
pubmed-article:3238822pubmed:authorpubmed-author:NiklassonFFlld:pubmed
pubmed-article:3238822pubmed:issnTypePrintlld:pubmed
pubmed-article:3238822pubmed:volume93lld:pubmed
pubmed-article:3238822pubmed:ownerNLMlld:pubmed
pubmed-article:3238822pubmed:authorsCompleteYlld:pubmed
pubmed-article:3238822pubmed:pagination225-32lld:pubmed
pubmed-article:3238822pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:meshHeadingpubmed-meshheading:3238822-...lld:pubmed
pubmed-article:3238822pubmed:year1988lld:pubmed
pubmed-article:3238822pubmed:articleTitleHypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid.lld:pubmed
pubmed-article:3238822pubmed:affiliationDepartment of Clinical Chemistry, University Hospital, Uppsala, Sweden.lld:pubmed
pubmed-article:3238822pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3238822pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3238822lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3238822lld:pubmed